Amedeo's Top 20

Amedeo Smart

Independent Medical Education


12 May 2014

Multidisciplinary Journal Club

  1. Anderson ST, Kaforou M, Brent AJ, Wright VJ, et al.
    Diagnosis of Childhood Tuberculosis and Host RNA Expression in Africa.
    N Engl J Med 2014;370:1712-1723.

  1. Jain S, Mayer KH.
    Practical guidance for nonoccupational postexposure prophylaxis to prevent HIV infection: an editorial review.
    AIDS 2014.

  2. Karceski S.
    The RESTORE trial: What did we learn about multiple sclerosis?
    Neurology 2014;82:e155-7.

  3. Cairncross JG, Wang M, Jenkins RB, Shaw EG, et al.
    Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH.
    J Clin Oncol 2014;32:783-90.

  4. Farias AQ, Silvestre OM, Garcia-Tsao G, da Costa Seguro LF, et al.
    Serum B-type natriuretic peptide in the initial workup of patients with new onset ascites: a diagnostic accuracy study.
    Hepatology 2014;59:1043-51.

  1. Mosconi L, Murray J, Tsui WH, Li Y, et al.
    Brain imaging of cognitively normal individuals with 2 parents affected by late-onset AD.
    Neurology 2014.

  2. Brose MS, Nutting CM, Jarzab B, Elisei R, et al.
    Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial.
    Lancet 2014.

  3. Wright NC, Looker AC, Saag KG, Curtis JR, et al.
    The Recent Prevalence of Osteoporosis and Low Bone Mass in the United States Based on Bone Mineral Density at the Femoral Neck or Lumbar Spine.
    J Bone Miner Res 2014.

  4. Roux S, Cabana F, Carrier N, Beaulieu M, et al.
    The World Health Organization Fracture Risk Assessment Tool (FRAX) Underestimates Incident and Recurrent Fractures in Consecutive Patients With Fragility Fractures.
    J Clin Endocrinol Metab 2014.

  5. Howlader N, Altekruse SF, Li CI, Chen VW, et al.
    US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status.
    J Natl Cancer Inst 2014.

  1. Charalambous S , Grant AD, Innes C, Hoffmann CJ, et al.
    Association of isoniazid preventive therapy with lower early mortality in individuals on antiretroviral therapy in a workplace programme.
    AIDS 2010;24 S:S5-13.

  2. Carapetis JR, Jacoby P, Carville K, Joel Ang SJ, et al.
    Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group A streptococcal infections.
    Clin Infect Dis 2014.

  3. Zetola NM, Shin SS, Tumedi KA, Moeti K, et al.
    Mixed Mycobacterium tuberculosis complex infections and false negative results for Gene Xpert MTB/RIF rifampin-resistance are associated with poor clinical outcomes.
    J Clin Microbiol 2014.

  4. Bradshaw PT, Ibrahim JG, Khankari N, Cleveland RJ, et al.
    Post-diagnosis physical activity and survival after breast cancer diagnosis: the Long Island Breast Cancer Study.
    Breast Cancer Res Treat 2014.

  5. Al-Shahi Salman R, White PM, Counsell CE, du Plessis J, et al.
    Outcome after conservative management or intervention for unruptured brain arteriovenous malformations.
    JAMA 2014;311:1661-9.

  1. van Wijk RM, van Vlimmeren LA, Groothuis-Oudshoorn CG, Van der Ploeg CP, et al.
    Helmet therapy in infants with positional skull deformation: randomised controlled trial.
    BMJ 2014;348:g2741.

  2. Zaman S, Narayan A, Thiagalingam A, Sivagangabalan G, et al.
    Long-Term Arrhythmia-Free Survival in Patients with Severe Left Ventricular Dysfunction and No Inducible Ventricular Tachycardia Post Myocardial Infarction.
    Circulation 2013.

  3. Kuhn L, Hunt G, Technau KG, Coovadia A, et al.
    Drug resistance among newly diagnosed HIV-infected children in the era of more efficacious antiretroviral prophylaxis.
    AIDS 2014.

  4. Kerber KA, Zahuranec DB, Brown DL, Meurer WJ, et al.
    Stroke Risk After Non-Stroke ED Dizziness Presentations: A Population-Based Cohort Study.
    Ann Neurol 2014.

  5. de Biase D, Cesari V, Visani M, Casadei GP, et al.
    HIGH SENSITIVITY BRAF MUTATION ANALYSIS: BRAF V600E IS ACQUIRED EARLY DURING TUMOR DEVELOPMENT BUT IS HETEROGENEOUSLY DISTRIBUTED IN A SUBSET OF PAPILLARY THYROID CARCINOMAS.
    J Clin Endocrinol Metab 2014.


more..


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016